Immunotherapy Promises New Approach to Fighting Cancers, Business and Industry Trends Analysis

  Bristol-Myers Squibb Co., Merck & Co. and Roche Holding AG, among others, are developing immunotherapy drugs to fight cancer.  The drugs are based on a strategy to stimulate and/or suppress the immune system in order to help the body fight cancer, infection, and other diseases.  Some types of immunotherapies only target certain cells of the immune system.  Others affect the immune system in a general way.  Types of immunotherapy include cytokines, vaccines and certain monoclonal antibodies.  A more recent class of these drugs is called checkpoint inhibitors which block normal proteins on cancer cells.  Advancements in genetic sequencing and…

A Representative List of Organizations that Have Used our Research and Products: